Pond Technologies Holdings Inc. (TSX.V: POND) is pleased to announce that on August 23, 2018, it entered into a non-binding letter of intent (“LOI”) to acquire all of the issued and outstanding shares (the “Purchased Shares”) of Regenurex Health Corporation, (“Regenurex”) a British Columbia based owner and operator of an algae production facility, engaged in the cultivation and extraction of astaxanthin, a valuable nutraceutical product.
Pond Technologies enters into Non-Binding Letter of Intent to acquire Regenurex Health Corporation
